We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Industrials 3.56%
3 Consumer Discretionary 3.21%
4 Technology 3.1%
5 Healthcare 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRBI icon
1576
Red River Bancshares
RRBI
$674M
$27K ﹤0.01%
709
+596
+527% +$29.9K
SIMO icon
1577
Silicon Motion
SIMO
$7.6B
$27K ﹤0.01%
728
-112
-13% -$4.84K
SLRC icon
1578
SLR Investment Corp
SLRC
$706M
$27K ﹤0.01%
+2,315
New +$42.1K
TMV icon
1579
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$194M
$27K ﹤0.01%
2,040
+460
+29% +$10.1K
USNA icon
1580
Usana Health Sciences
USNA
$254M
$27K ﹤0.01%
+465
New +$32.3K
VRTX icon
1581
Vertex Pharmaceuticals
VRTX
$134B
$27K ﹤0.01%
113
-784
-87% -$180K
VSAT icon
1582
Viasat
VSAT
$11.6B
$27K ﹤0.01%
+742
New +$42.8K
ONC
1583
BeOne Medicines Ltd
ONC
$40.6B
$27K ﹤0.01%
216
-595
-73% -$93K
CHA
1584
DELISTED
China Telecom Corporation, LTD
CHA
$27K ﹤0.01%
+885
New +$33K
AC
1585
DELISTED
Associated Capital Group
AC
$26K ﹤0.01%
867
+781
+908% +$31.3K
ADAP
1586
DELISTED
Adaptimmune Therapeutics
ADAP
$26K ﹤0.01%
9,591
+9,429
+5,820% +$31.3K
CHT icon
1587
Chunghwa Telecom
CHT
$32.9B
$26K ﹤0.01%
721
+684
+1,849% +$24.7K
DVA icon
1588
DaVita
DVA
$11.4B
$26K ﹤0.01%
339
-1,006
-75% -$79.1K
EQX icon
1589
Equinox Gold
EQX
$13.6B
$26K ﹤0.01%
3,914
+3,826
+4,348% +$30.1K
GGB icon
1590
Gerdau
GGB
$9.21B
$26K ﹤0.01%
17,382
-2,549
-13% -$8.08K
GILT icon
1591
Gilat Satellite Networks
GILT
$846M
$26K ﹤0.01%
3,733
+2,029
+119% +$17.5K
INDA icon
1592
iShares MSCI India ETF
INDA
$6.6B
$26K ﹤0.01%
+1,080
New +$34.5K
IQ icon
1593
iQIYI
IQ
$1.3B
$26K ﹤0.01%
1,481
-8,653
-85% -$194K
MOH icon
1594
Molina Healthcare
MOH
$10.2B
$26K ﹤0.01%
189
-211
-53% -$28.2K
NFE icon
1595
New Fortress Energy
NFE
$94.1M
$26K ﹤0.01%
2,673
-983
-27% -$13.7K
PACB icon
1596
Pacific Biosciences
PACB
$354M
$26K ﹤0.01%
8,389
+1,332
+19% +$5.45K
PFBC icon
1597
Preferred Bank
PFBC
$1.26B
$26K ﹤0.01%
+760
New +$39.8K
SABA
1598
Saba Capital Income & Opportunities Fund II
SABA
$222M
$26K ﹤0.01%
2,470
+2,453
+14,429% +$28.8K
TPB icon
1599
Turning Point Brands
TPB
$1.77B
$26K ﹤0.01%
+1,227
New +$28.7K
WCC
1600
WESCO International
WCC
$17.8B
$26K ﹤0.01%
1,133
+502
+80% +$21.4K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.